Author: healthadmin

A comparative study presented at ESGE Days 2026 found that endoscopic sleeve gastroplasty (ESG) was associated with significantly greater short-term weight loss than oral semaglutide in obese adults. This retrospective cohort study included 150 patients treated in routine clinical practice and assessed 6-month outcomes. Patients receiving ESG achieved a mean total weight loss of 12.7% compared to 8.7% for patients receiving oral semaglutide 14 mg, corresponding to a mean difference of approximately 4.0% (p=0.0001). This difference remained significant after adjusting for baseline characteristics such as age, gender, BMI, and diabetes status and was supported by multiple sensitivity analyses. Endoscopic sleeve…

Read More

As cannabis use increases among older Americans, experts at Stanford Medicine warn that today’s cannabis products are much more potent than many people realize and may carry serious health risks. Eloise Theisen never expected to become a medical cannabis expert. A geriatric nurse currently focusing on cannabis therapy at Stanford University, she first turned to cannabis on her own after a serious car accident left her with chronic pain that other treatments failed to alleviate. When I later returned to work at an oncology clinic, I realized that many patients were already using or considering using cannabis without the guidance…

Read More

Purchases of electronic medical record systems for emergency medicine declined significantly in 2025 as market uncertainty hampered purchasing decisions among hospitals and health systems, according to data from KLAS Research. The number of hospitals affected by EHR purchasing decisions decreased by 40% compared to 2024 and by nearly 50% compared to 2023, KLAS Research reported in its 2025 EHR Market Share Report. Analysts at KLAS Research say continued questions over government policy have contributed to the hesitation, at the same time many health systems have shifted investments toward technologies with more immediate economic benefits, such as AI and other solutions…

Read More

Researchers at the University of Texas Medical Branch (UTMB) have identified how a key enzyme called ATR protects DNA from destruction as cells copy damaged genetic material. This discovery could have implications for how certain cancer drugs are developed. Funded by the National Institutes of Health; genes and developmentthis study shows how ATR helps stabilize the cell’s DNA copying machinery and prevent chromosome breakage during replication arrest. Every time a cell divides, it must replicate DNA, the spiral-shaped molecules that make up chromosomes and carry genetic information. To do this, cells unzip and copy billions of DNA building blocks, known…

Read More

Breathing in common air pollutants over many years can significantly increase the risk of developing certain neurodegenerative diseases, and the environment has been implicated in contributing to cognitive decline. New research published in JAMA network open found that long-term exposure to particulate matter and nitrogen dioxide is associated with increased rates of Lewy body dementia and Parkinson’s disease dementia. These results suggest that improving air quality may act as a preventive measure to protect brain health in older adults. Lewy body dementia and Parkinson’s disease dementia are related neurological conditions that significantly affect memory, thinking, and behavior. Both diseases involve…

Read More

Get the latest news in health technology, digital health and health AI with this weekly overview. News for the week from May 11th to May 15th. Headspace app launches on Apple Watch Mental health companion Headspace has debuted a newly updated Apple Watch app to help users bring mindfulness to life. With permission, the app uses data from Apple Health to identify “moments when members are naturally more receptive to mindful breaks.” The app offers meditations, breathing nudges, a tap-to-calm interface during stressful moments, sleep support, and on-the-go collections. Apple Watch sessions contribute to member progress and streaks. “Breathwork is…

Read More

Vitamin B2 is essential for human health, but new research suggests it may help cancer cells survive. Vitamin B2, also known as riboflavin, cannot be produced by the body and must be obtained from food sources such as dairy products, eggs, meat, and green vegetables. Once absorbed, vitamins are converted into molecules that protect cells from oxidative damage and support other important biological functions. Scientists at the Rudolf Virchow Center (RVZ) at Julius-Maximilians-Universität Würzburg (JMU) have discovered that this protective effect may have a serious drawback. Their findings show that vitamin B2 metabolism can also prevent the destruction of cancer…

Read More

A single dose of the psychedelic substance psilocybin can rapidly reduce symptoms of depression within just a few days. This is shown by the first randomized, double-blind study of psilocybin for depression in Sweden. The effects lasted for more than three months, according to researchers at the Karolinska Institutet. Depression is a public health problem that causes great suffering. SSRI drugs are the most common treatment, but many patients do not respond to them. It can also take several weeks to take effect, and side effects are common. Psilocybin, found in so-called magic mushrooms, has been shown to have antidepressant…

Read More

After doubling sales of Requenby, its Alzheimer’s disease drug partnered with Biogen, in fiscal 2025, Eisai expects annual sales of the drug to reach $900 million in 2026, with the drug well on its way to becoming a blockbuster. In the three years since amyloid beta-directed antibodies have been on the market, sales have gotten off to a relatively slow start. After being approved by the FDA in 2023, the drug generated 44.3 billion yen ($279 million) for Eisai in its 2024 fiscal year and 88 billion yen ($554.6 million) last year. Eisai’s fiscal year runs from the beginning of…

Read More

The U.S. Supreme Court has issued an emergency order temporarily blocking a Louisiana federal appeals court ruling banning the abortion drug mifepristone from being prescribed over the phone or by mail in the United States (PDF). The new ruling allows telemedicine access to mifepristone to remain in place while the case progresses in lower courts, and the case could eventually return to the Supreme Court. This is the second time this month that the Supreme Court has ruled against Louisiana. On May 4, three days after a lower court ruling immediately halted access to mifepristone, the Supreme Court issued an…

Read More